Opko Health, Inc.
Clinical trials sponsored by Opko Health, Inc., explained in plain language.
-
New hope for kids with kidney disease: experimental vitamin d pill enters trial
Disease control Not yet recruitingThis study tests an experimental extended-release capsule (CTAP101) in 40 children aged 8 to 17 with moderate chronic kidney disease, secondary hyperparathyroidism, and low vitamin D. Participants take one capsule daily at bedtime for 8 weeks. The goal is to see how the drug move…
Phase: PHASE2 • Sponsor: OPKO Health, Inc. • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
New MASH drug OPK-88006 enters early safety testing
Knowledge-focused Not yet recruitingThis early-stage study tests a new drug called OPK-88006 in 30 people—first in healthy volunteers, then in those with MASH (a liver condition). The goal is to see if the drug is safe, how the body processes it, and whether it affects weight, liver fat, and other health markers. N…
Phase: PHASE1, PHASE2 • Sponsor: OPKO Health, Inc. • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC